CBD Concentrate Leads Sales After Best Brand Recognition By Leading CBD Directory

NEW BRUNSWICK, NJ / ACCESSWIRE / February 13, 2019 / A pure CBD oil concentrate has been a steady top-seller after being designated with ‘best value’ product status by a leading CBD product directory, see here https://cbdrevu.com/cbdpure-hemp-oil-cbd/.

CBD (cannabidiol) is experiencing unprecedented popularity among consumers as a result of substantial publicity about a number of potential benefits, even those most of those highly touted benefits are not proven. Actual scientific research is needed to examine such claims about hemp based CBD as well as marijuana., Legal restrictions on these substances have hindered the ability of scientists to do the appropriate research in prior years. Going forward more research should be on the horizon, at least for hemp-derived CBD, since the laws surrounding hemp changed in late 2018. Congress essentially legalized hemp in late 2018 with The Farm Bill and that changed landscape significantly. Hemp is a variety of the cannabis plant species that contains, at best, only tiny amounts of the psychoactive substance THC, which is the substance in marijuana plants that produces a psychoactive response.

The best CBD sales are from CBD sourced from industrial hemp. So, CBD products should continue to expand, according to projections from leading industry watchers. Over the past three years most CBD sales have been from concentrated CBD oils and from CBD capsules but industry experts suggest that CBD edibles are expected to emerge as a leading form of CBD with CBD gummies expected to lead in this niche. In 2018, the term ‘CBD gummies’ was one of the top most searched for terms on Google coming in at number three.

There are over 100 cannabinoids contained in the cannabis sativa plant. Both hemp and marijuana contain CBD. But, as indicated above most CBD is derived from hemp since hemp has only negligible amounts of the euphoria producing THC. CBD sourced from marijuana would be high in THC and illegal at the Federal level as well as most U.S. states, with the exception of states with medical marijuana programs.

In addition to the expanding CBD niche, more dramatic growth is projected for the legal cannabis industry in 2019. As of the New Year, thirty-three states in addition to the Washington, DC have legalized cannabis for medicinal use, while 10 states permit recreational adult use. Sales in the United States for medical and recreational use combined in 2019 are expected to reach $5.9 billion and $7.0 billion, respectively, up 28% and 21% from 2018. In 2019, the total number of registered medical cannabis patients in the United States is projected to reach 2.4 million, up 26% from 1.9 million patients in 2018.

As the market for CBD products continues to explode, consumers are urged to be cautious when selecting CBD products. Accurate product labeling is an issue for CBD products as well as for the nutritional supplements market in general. Recent studies have shown that many of the CBD products currently available do not accurately disclose the amount of actual CBD in their products. This is a problem that plagues the nutritional supplements market as a whole and not just the CBD market. Product directories such as CBDReVu can help consumers sort through the various product offerings for a number of basic buying criteria such as whether of the product uses an independent testing lab for analysis of the actual ingredients within the product. CBDReVu compiles and presents information as disclosed by the various CBD companies labeling and their websites, thus providing consumers with a comprehensive starting point to shop for CBD products.